A Combination of Drug-Eluting Stents and Bioresorbable Vascular Scaffolds in the Treatment of Multivessel Coronary Artery Disease
- PMID: 27606119
- PMCID: PMC4996302
- DOI: 10.18295/squmj.2016.16.03.017
A Combination of Drug-Eluting Stents and Bioresorbable Vascular Scaffolds in the Treatment of Multivessel Coronary Artery Disease
Abstract
Optimal management of multivessel coronary artery disease can be complex. We report a 67-year-old male patient who was admitted to the Padua University Hospital, Padua, Italy, in 2014 with a non-ST-elevation myocardial infarction. Coronary angiography showed diffuse multiple sub-occlusive lesions of the proximal and distal left coronary vessels involving a long segment of the vessel. On intravascular ultrasonography (IVUS), the left main artery was moderately diseased with critically stenotic and calcified branch ostia. A successful percutaneous coronary intervention using the T-stenting and small protrusion technique with two drug-eluting stents (DES) was performed on the left main artery and its main branches. Two bioresorbable vascular scaffolds were also deployed in overlap at the mid to distal segments of the left anterior descending artery and overlapping a previous DES at the proximal segment. The full expansion and apposition of the struts and scaffolds to the vessel wall without residual stenosis was confirmed by IVUS.
Keywords: Case Report; Coronary Stenosis; Drug-Eluting Stents; Italy; Myocardial Infarction; Percutaneous Coronary Intervention; Ultrasonography.
Figures




Similar articles
-
Guide-catheter extension system facilitated multiple bioresorbable vascular scaffolds (ABSORB®) delivery in a very long and resistant coronary artery lesion.Cardiovasc Revasc Med. 2014 Mar;15(2):117-20. doi: 10.1016/j.carrev.2013.08.004. Epub 2013 Sep 17. Cardiovasc Revasc Med. 2014. PMID: 24054502
-
Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).JACC Cardiovasc Interv. 2014 Oct;7(10):1093-102. doi: 10.1016/j.jcin.2014.04.017. Epub 2014 Sep 17. JACC Cardiovasc Interv. 2014. PMID: 25240540
-
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005. JACC Cardiovasc Interv. 2013. PMID: 24355114
-
Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.JACC Cardiovasc Interv. 2013 Mar;6(3):211-21. doi: 10.1016/j.jcin.2013.01.132. JACC Cardiovasc Interv. 2013. PMID: 23517830 Review.
-
The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.Cardiovasc Ther. 2015 Dec;33(6):360-6. doi: 10.1111/1755-5922.12160. Cardiovasc Ther. 2015. PMID: 26363283 Review.
References
-
- Parikh PB, Kirtane AJ, Moses JW. Management of multivessel coronary artery disease. Panminerva Med. 2013;55:311–26. - PubMed
-
- Kolh P, Windecker S, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) - Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur J Cardiothorac Surg. 2014;46:517–92. doi: 10.1093/ejcts/ezu366. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources